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Hepcidin, the iron hormone, is regulated by a number of stimulatory and inhibitory signals. The
cAMP responsive element binding protein 3-like 3 (CREB3L3) mediates hepcidin response to en-
doplasmic reticulum (ER) stress. In this study we asked whether hepcidin response to ER stress also
requires the small mother against decapentaplegic (SMAD)-1/5/8 pathway, which has a major role
in hepcidin regulation in response to iron and other stimuli. We analyzed hepcidin mRNA expres-
sion and promoter activity in response to ER stressors in HepG2 cells in the presence of the bone
morphogenetic protein (BMP) type I receptor inhibitor LDN-193189, mutated hepcidin promoter
or small interfering RNA against different SMAD proteins. We then used a similar approach in vivo
in wild-type, Smad1/5, or Creb3l3/ animals undergoing ER stress. In vitro, LDN-193189 prevented
hepcidin mRNA induction by different ER stressors. Seemingly, mutation of a BMP-responsive
element in the hepcidin promoter prevented ER stress-mediated up-regulation. Moreover, in vitro
silencing of SMAD proteins by small interfering RNA, in particular SMAD5, blunted hepcidin re-
sponse to ER stress. On the contrary, hepcidin induction by ER stress was maintained when using
antibodies against canonical BMP receptor ligands. In vivo, hepcidin was induced by ER stress and
prevented by LDN-193189. In addition, in Smad1/5 knockout mice, ER stress was unable to induce
hepcidin expression. Finally, in Creb3l3 knockout mice, in response to ER stress, SMAD1/5 were
correctly phosphorylated and hepcidin induction was still appreciable, although to a lesser extent
as compared with the control mice. In conclusion, our study indicates that hepcidin induction by
ER stress involves the central regulatory SMAD1/5 pathway. (Endocrinology 157: 3935–3945, 2016)
Hepcidin (encoded by the HAMP gene) is a defensin-like cysteine-rich antimicrobial peptide now recog-
nized as the major player in iron homeostasis and a central
humoral mediator of innate immunity and host defense
(1–4). The peptide retains some antifungal and antimi-
crobial activity in vitro (2), but its main biological effect is
to prevent invading pathogens from using iron sources to
grow and proliferate during infection. To do so, hepcidin
binds and degrades the sole iron importer in mammals (5),
a multidomain transmembrane protein encoded by the
SLC40A1 gene named ferroportin (FPN1) (6–8). Hepci-
din binding to FPN1 at the cell surface through its N-ter-
minus domain results in FPN1 ubiquitination and inter-
nalization, ultimately leading to degradation in lysosomes
(9, 10). This causes cessation of iron transfer through the
basolateral sites of absorbing enterocytes, placental syn-
cityotrophoblasts, hepatocytes, and tissue macrophages.
Hepcidin production by the hepatocytes is induced by
a number of stimuli, in particular, iron, through the bone
morphogenetic protein (BMP)-small mother against de-
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capentaplegic family of protein (SMAD) pathway (11,
12), and inflammatory signals, particularly IL-6 (13–17),
IL-1 (18), IL-22 (19, 20), and activin B (21, 22).
The SMAD1/5/8 signaling pathway has a central role in
the physiological regulation of hepcidin transcription.
Iron sensing occurs through the interaction of transferrin-
iron and BMPs within a multiprotein complex at the
plasma membrane made by BMP receptors, a BMP core-
ceptor (hemojuvelin), and a number of ancillary proteins
(including HFE and the second transferrin receptor). BMP
ligands bind to type I (ie, activin receptor-like kinase
[ALK]-1, ALK2, ALK3, and ALK6) and type II (ie, BMP
receptor II, activin receptor ACVR2A, or ACVR2B) re-
ceptors and turn on a signaling cascade involving the phos-
phorylation of the SMAD1/5/8 complex (receptor-asso-
ciated SMADs) that binds to SMAD4 (common partner
SMAD) (23). Once formed, the SMAD complex translo-
cates to the nucleus and binds specific sequence motifs in
Hamp promoter (the proximal BMP responsive element
[BMP-RE]-1 and the distal BMP-RE2) (17, 24, 25), acti-
vating the transcription of hepcidin (26). In inflammation,
activin B uses a similar signaling cascade via BMP type I
receptors ALK2 and ALK3 and SMAD1/5/8 to induce
hepcidin (21, 22) in conjunction with the IL-6-STAT3
pathway.
In addition to extracellular stimuli, hepcidin has been
recently reported to respond to intracellular stress, namely
endoplasmic reticulum (ER) stress. We have found that
cAMP response element binding protein 3-like 3
(CREB3L3; also known as CREBH), an ER stress-associ-
ated, liver-specific transcription factor originally involved in
the induction of acute-phase response genes such as serum
amyloid protein (SAP) and C-reactive protein (CRP), is con-
stitutively engaged on hepcidin promoter and transactivates
it in response to ER stress, both in vitro and in vivo (27).
This finding has been confirmed and expanded to other
pathophysiologic models by subsequent studies (28–30).
More recently, CREBH has been also involved in hepcidin
response to gluconeogenic signals during nutrient dysregu-
lation (31) and to hypoxia (32).
Due to its central role in hepcidin transcription (23), we
wondered whether the SMAD1/5/8 pathway might be also
involved in the hepcidin response to ER stress. To address
this question we used an in vitro and in vivo approach.
Materials and Methods
Cell cultures
HepG2 human hepatoma cells were cultured in MEM (con-
taining 1 g/L glucose) supplemented with 1 mM glutamine, 100
U/mL penicillin, 100 g/mL streptomycin, and 10% heat-inac-
tivated fetal bovine serum, in a 5% CO2 atmosphere at 37°C.
For ER stress experiments, HepG2 cells were incubated in the
presence of tunicamycin (Tm; 10 g/mL dissolved in dimethyl-
sulfoxide) or brefeldin A (BFA; 20 g/mL dissolved in dimeth-
ylsulfoxide) for the indicated time (all reagents were from Sigma-
Aldrich). LDN-193189 (100 nM, provided by Professor H. Y
Lin, Massachusetts General Hospital-Harvard Medical School,
Boston, Massachusetts) was used as the inhibitor of the BMP-
SMAD pathway. 4-Phenylbutyric acid (4-PBA; Sigma-Aldrich)
was used as inhibitor of ER stress.
In specific experiments, cells were incubated with 30 g/mL
anti human activin B beta B subunit (antiactivin B), anti human
BMP2/BMP4 (anti-BMP2/4), and antihuman BMP6 (anti-BMP6)
antibodies, all from R&D Systems.
Real-time quantitative RT-PCR (qRT-PCR) and
semiquantitative RT-PCR
Total cellular RNA was obtained by incubating cells in iScript
RT-qPCR sample preparation reagent (Bio-Rad Laboratories)
according to the manufacturer’s instructions. Total liver RNA
was extracted using Trizol reagent (Invitrogen) following the
manufacturer’s instructions.
cDNA was generated by reverse transcription of 2 L of
iScript buffer (for HepG2 RNA) or 1 g (for liver RNA) with 200
U ImProm-II reverse transcriptase (Promega) following the man-
ufacturer’s instruction. Expression of mRNAs was analyzed us-
ing SsoFast EVAGreen supermix (Bio-Rad Laboratories). Primer
sequences are listed in Table 1.
Cycling conditions were 30 seconds at 98°C followed by 40
cycles of 2 seconds at 98°C and 10 seconds at 60°C. After 40
amplification cycles, threshold cycle values were automatically
calculated using the default settings of the CFX Manager (Bio-
Rad Laboratories; version 2.0). At the end of the PCR run, melt-
ing curves of the amplified products were obtained and used to
determine the specificity of the amplification reaction. In each
experiment, the change of specific mRNA expression was nor-
malized on RPL19 housekeeping mRNAs.
XBP1 mRNA spliced forms were analyzed by semiquantita-
tive RT-PCR using cDNA obtained as specified above from cells
or mouse livers. PCR products were run on 3% agarose gels.
Primers are reported in Table 1.
Western blot analysis
Liver sections were homogenized in radioimmunoprecipita-
tion assay buffer (1 Tris buffered saline, 0.1% sodium dodecyl
sulfate, 1% Triton X-100, 1% sodium deoxycholate, 1 mM
EDTA) supplemented with protease and phosphatase inhibitors
(Sigma-Aldrich) to obtain the total protein extracts. After cen-
trifugation at 14 000  g at 4°C for 15 minutes, the supernatant
was collected and proteins concentration assayed by the Brad-
ford method. Total extracts were run on 12% SDS-PAGE or
NuPAGE NOVEX 4%–12% bis-tris gel (Invitrogen), trans-
ferred to nitrocellulose membranes, and incubated with rabbit
antiphospho-SMAD1/5 (Thermo Scientific), rabbit monoclonal
antihepcidin (Abcam), or mouse anti--actin (Sigma-Aldrich)
followed by the appropriate horseradish peroxidase-conjugate
secondary antibodies. Western blot analysis was performed us-
ing Western Lightning Plus ECL (PerkinElmer) according to the
manufacturer’s instruction, and cross-reactivity was detected by
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Molecular Imager ChemiDoc XRSwith Image Lab Software
(Bio-Rad Laboratories).
Plasmids, small interfering RNAs (siRNAs)
transfection and luciferase assay
HepG2 cells were transfected with siRNAs against SMAD1,
SMAD5, and SMAD8 (OnTARGET-Plus siGenome; Dharma-
con) to prevent single SMAD expression. Negative control
siRNA (unspecific RNA interference [US RNAi], scrambled se-
quence) was used as control.
Forty-eight hours after transfection, cells were treated for 5
hours with tunicamycin (10 g/mL) and analyzed for specific
mRNA expression normalized on RPL19 housekeeping gene
expression.
The wild-type murine hepcidin promoter region as well as
luciferase analysis were described elsewhere (27).
Mutation of the BMP-RE was generated using the QuikChange
site-directed mutagenesis kit (Stratagene) and subjected to gene se-
quencing, as reported elsewhere (17).
Animal studies
Animal protocols were approved by the Ethics Committee for
Animal Studies at the University of Modena and Reggio Emilia
and the Institutional Animal Care and Use Committee at Mas-
sachusetts General Hospital. All animal experiments were car-
ried out in accordance with the European Union Directive
2010/63/EU.
C57BL/6Crl male mice aged 8–10 weeks were allowed free
access to water and fed a standard chow diet in pellets. For ER
stress treatment, animals were treated with Tm (2 mg/kg, ip) or
vehicle (dextrose) as reported elsewhere (27) and killed at 1, 3,
or 5 hours after injection. To inhibit BMP-SMAD signaling, mice
received a single dose of vehicle or Tm (2 mg/kg) and LDN-
193189 (3 mg/kg, ip) or vehicle (cyclodextrin) at time 0, and a
second dose of LDN-193189 or vehicle after 2 hours. All animals
were killed 5 hours after the first injection for analysis.
Creb3l3 wild type and Creb3l3/ null male and female mice
(The Jackson Laboratory) at 8 weeks of age were treated with Tm
or vehicle as above and killed at 5 hours.
Mice homozygous for floxed Smad1 and Smad5 alleles
(Smad1/5) on a mixed C57BL/6-129-CD1 background were
kindly provided by Elizabeth Robertson (University of Oxford,
Oxford, United Kingdom) and An Zwijsen (VIB and KU Leuven,
Leuven, Belgium) (33, 34). Smad1/5 mice were crossed with al-
bumin-Cre mice on a C57BL/6J background (Jackson; stock
number 003574) to generate littermate Smad1/5 Cre (control)
and Smad1/5 Cre (hepatocyte-specific double knockout) mice.
Littermate Smad1/5 Cre, and Smad1/5 Cre male mice at 8
weeks of age were treated with Tm or vehicle as described above
and killed at 5 hours.
In each experimental set, the liver was collected at the time the
animals were killed, and total RNA and proteins were extracted
and analyzed.
Iron and transferrin saturation measurements
Serum iron and transferrin saturation measurements have
been performed as reported elsewhere (22).
Statistics
All data presented in the figures were expressed as means 
SEM. All data were tested for normal distribution (Kolmogorov-
Smirnov’s test). Statistical significance was evaluated by a Stu-
dent’s t test when making comparisons between two groups.
When making multiple statistical comparisons, a one-way
ANOVA with a Tukey or Dunnett’s post hoc tests was used for
normally distributed data, depending on the presence or absence
of homoscedasticity. For skewed data, the Kruskal-Wallis test
was used. In all statistical analyses, P  .05 was considered
significant.
All analyses were conducted using Prism 5 for Mac OS X
version 5.0a software (GraphPad Software Inc).
Results
Hepcidin response to ER stress requires the
SMAD1/5/8 pathway in vitro
To demonstrate the involvement of the SMAD1/5/8
pathway mediated by the BMP type I receptors ALK2 and
ALK3 (21, 35–37) in hepcidin activation, we used a com-
plementary approach by blocking either the ligand-recep-
tor interaction or receptor activity. To the first end, we
Table 1. Sequence of the Primers Used in Quantitative










































/endo/article/157/10/3935/2758371 by guest on 19 February 2021
used specific antibodies against ALK2 and ALK3 receptor
ligands, namely activin-B, BMP2/4, and BMP6 (Figure
1A). Then we used LDN-193189 (38), a small molecule that
strongly inhibits the activity of the BMP type I receptors
ALK2 and ALK3 (Figure 1B). In both cases, hepcidin
mRNA expression was reduced, par-
ticularly when using antibody against
BMP ligands or LDN-193189 (Figure
1A). A known ER stressor, Tm, which
prevents the N-glycosylation of nas-
cent proteins, led to a significant in-
crease of hepcidin expression (Figure
1, C and D, light gray bars); however,
whereas ligand-specific antibodies
were unable to block the stimulatory
effect of Tm (Figure 1C), cotreatment
with LDN-193189 and Tm reduced
ER stress-mediated activation of hep-
cidin (Figure 1D, dark gray bars). The
appearance of the XBP1 spliced
forms, a specific event that occurs
during ER stress response, indicated
proper induction of ER stress (Figure
1D, lower panels). A similar effect
was obtained when using BFA, an ER
stress inducer that inhibits the trans-
port of proteins from ER to Golgi, in
association with LDN-193189 (Sup-
plemental Figure 1A).
To prove that ER stress was di-
rectly involved in hepcidin up-regula-
tion, we used a well-known ER stress
inhibitor, 4-PBA (39). Exposure of
HepG2 cells to increasing doses of
4-PBA led to a progressive and consis-
tent reduction of hepcidin activation
by Tm (Supplemental Figure 2A). Ac-
cordingly, induction of BiP (binding
immunoglobulin protein) and CHOP
(CCAAT enhancer binding protein
homologous protein), two well-
known ER stress markers, was simi-
larly reduced by 4-PBA (Supplemen-
tal Figure 2, B and C).
The SMAD1/5/8 signaling requires
a BMP-RE, a palindromic GGCGCC
sequence, highly conserved between
human, rat, and mouse hepcidin pro-
moters (17). To prove the critical im-
portance of this signaling pathway for
hepcidin activation under ER stress,
HepG2 cells were transfected with
wild-type (mHamp WT-Luc) or hepcidin promoter con-
struct mutated in the conserved palindromic sequence
(mHamp BMP-REmut-Luc), fused to the luciferase gene.
The activity of the hepcidin promoter was significantly re-




Figure 1. The SMAD pathway is required for ER stress-mediated HAMP induction in vitro. A and
C, HepG2 cells were treated for 5 hours with 30 g/mL antiactivin B, anti BMP2/4, anti-BMP6
either alone (A) or in the presence of Tm (C). Total RNA was extracted and analyzed for hepcidin
(HAMP) expression normalized to RPL19 housekeeping mRNA expression. B and D, HepG2 cells
were treated for 5 hours in the presence of LDN-193189 (LDN) either alone (B) or in the presence
of Tm (D). Hepcidin (HAMP) mRNA was analyzed by real-time PCR and normalized to RPL19
housekeeping mRNA expression. XBP1 mRNA splicing forms were analyzed by semiquantitative
PCR and run on 3% agarose gel (D, lower panel). E, HepG2 cells were transfected with WT and
BMP-RE (BMP responsive element) mutated Hamp promoter luciferase constructs. Luciferase
units were analyzed in respect to total proteins content and expressed as fold change over wild-
type control promoter activity. F, HepG2 cells were transfected as in panel E and treated with Tm
for 5 hours. Luciferase units were analyzed in respect to total proteins content and expressed as
fold induction over control (vehicle treated cells). Data are expressed as fold change over the
control cells set to 1. Data are the mean  SEM of three (A and C) or five (B, D, E, and F)
independent experiments, each conducted in triplicate. P values are reported for comparisons
between indicated groups. Ab, antibody; Ctrl, control. *, P  .05; **, P  .01; ***, P  .001.
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Cells were then treated with either Tm or BFA. The wild-
type promoter activity was up-regulated by ER stressors,
whereas the presence of the BMP-RE mutation in the pro-
moter completely abolished the induction (Figure 1F and
Supplemental Figure 1B). Altogether these results prove that
a preserved SMAD1/5/8 pathway is required in vitro for
proper induction of hepcidin expression during ER stress.
To clarify the role of different SMADs in hepcidin re-
sponse to ER stress, we used siRNA technologies to pre-
vent the expression of single receptor-associated SMAD
molecules in HepG2 cells (Figure 2). As shown in Figure
2A (white bars), basal hepcidin mRNA expression was
dramatically down-regulated by SMAD5 silencing but not
by the inhibition of SMAD1 and SMAD8. After treatment
with Tm, cells transfected with SMAD1 or SMAD8 RNAi,
similarly to cells transfected with US RNAi, responded by
activating hepcidin expression, whereas cells silenced with
SMAD5 RNAi did not (Figure 2A, gray bars). Efficient
silencing of single SMADs was confirmed by the reduction
of SMAD1 (Figure 2B), SMAD5 (Figure 2C), and SMAD8
(Figure 2D) mRNAs. Interestingly, SMAD5 mRNA was
induced by Tm in all in vitro settings (Figure 2C).
Hepcidin response to ER stress requires induction
of the SMAD1/5/8 pathway in vivo model
To confirm a role for SMAD1/5/8 signaling in regulat-
ing hepcidin gene expression during ER stress in vivo, we
studied hepcidin expression in a murine model of ER
stress. C57BL/6 male wild-type mice were injected with a
single dose of Tm (2 mg/kg) or vehicle alone (Ctrl) ip and
killed at different time points. Tm treatment triggered
Hamp expression, peaking at 5 hours (Figure 3A). Induc-
tion of the SMAD1/5/8 pathway was confirmed by the
time-dependent appearance of Smad1/5 phosphorylation
and a concurrent Id1 mRNA up-regulation in animals
treated with Tm (Figure 3, B and C). Interestingly, mRNA
expression of activin B (Figure 3D) was significantly up-
regulated by Tm treatment (Figure 3D), whereas Bmp6
mRNA was not induced (Figure 3E). Individual SMAD
mRNA expression showed a trend toward increased lev-
els, which reached statistical significance at 3–5 hours af-
ter Tm treatment (Supplemental Figure 3, A–C). ER stress
markers were properly induced as shown by the increase
of Bip mRNA and the appearance of the splicing forms of
Xbp1 mRNA (Supplemental Figure 3D).
A B
C D
Figure 2. ER stress requires SMAD5 to induce hepcidin expression in vitro. A, HepG2 cells were transfected with indicated siRNAs to prevent the
expression of specific SMADs (SMAD1, SMAD5, or SMAD8) and treated for 5 hours with Tm or vehicle. US RNAi was used as control. Hepcidin
(HAMP) mRNA was analyzed by real-time PCR and normalized as compared with RPL19 housekeeping mRNA expression. B–D, Specific SMAD
mRNA expression was analyzed as in panel A. Data are expressed as fold change over control cells (vehicle treated cells) set to 1. Data are the
mean  SEM of three independent experiments, each conducted in triplicate. P values are reported for comparisons between control and
Tm-treated cells. ns, not significant. **, P  .01, ***, P  .001. §, P  .05, §§§, P  .001, statistical significance as compared with US RNAi
treated with vehicle.










Figure 3. ER stress induces Hamp expression and the SMAD pathway in vivo. A, Hamp mRNA expression was analyzed by real-time PCR and
normalized to Rpl19 housekeeping mRNA expression using total cDNA from liver of C57BL/6 male mice treated with Tm for the indicated time
points. B, Phosphorylation of SMAD1/5 was analyzed in total liver extracts obtained from C57BL/6 male mice treated with Tm for the indicated
time points. Densitometric analysis of phospho-SMAD1/5 signal normalized to -actin expression is shown in the lower panel. C–E, Id1 (C), ActB
(D), and Bmp6 (E) mRNA expressions were analyzed as in panel A. Data are expressed as fold change over the control mice set to 1. Data are the
mean  SEM of six to eight mice per group. P values are reported for comparisons between control and each time point Tm-treated mice. Ctrl,
control; ns not significant. *, P  .05; **, P  .01; ***, P  .001.
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To further clarify the role of the SMAD1/5/8 pathway,
we cotreated mice with Tm and the BMP-SMAD inhibitor
LDN-193189. Tm induced both Hamp (Figure 4A) and
Id1 (Figure 4B) mRNA expression in vivo, whereas the
concomitant injection of LDN-193189 completely abol-
ished Hamp and Id1 mRNA induction (Figure 4, A and B,
dark gray bars). Accordingly, hepcidin protein levels were
correctly increased by Tm, whereas this effect was blunted
by the concomitant administration of LDN-193189
(Figure 4C). ER stress induction is demonstrated by the
up-regulation of Bip mRNA and the appearance of Xbp1
spliced forms (Figure 4D).
In view of the results from both in vitro and in vivo
experiments, we investigated hepcidin response in the
double Smad1/5 hepatocyte conditional knockout mice
model undergoing ER stress. Smad1/5 Cre (control) and
Smad1/5 Cre (double knockout) male mice were treated
with an ip injection of Tm (2 mg/kg) and killed at 5 hours.
Although hepcidin mRNA induction was correctly up-
regulated in Smad1/5 Cre mice treated with Tm, Hamp
response was abolished in Smad1/5 Cre mice, indicating
the key role of SMAD1/5 complex for Hamp expression
after ER stress (Figure 5A). Similar results were obtained
when assessing hepcidin protein levels: in Smad1/5 Cre
mice, hepatic hepcidin synthesis was correctly induced af-
ter Tm treatment, whereas Smad1/5 Cre mice were un-
able to do so (Figure 5B). As expected, the SMAD1/5/8
pathway was not induced in double-knockout mice, as
A B
C D
Figure 4. The SMAD pathway is required for Hamp induction in vivo by tm. A and B, Hamp (A) and Id1 (B) mRNA expressions were analyzed by
real-time PCR and normalized to Rpl19 housekeeping mRNA expression using total cDNA from the liver of C57BL/6 male mice treated with Tm
together with LDN-193189 (LDN) for 5 hours. C, Hepcidin protein expression was analyzed using total liver extracts obtained from mice treated as
in panel A. Densitometric analysis of hepcidin signal normalized to -actin expression is shown in the lower panel. A representative immunoblot is
shown. D, Upper panel, Bip mRNA expression was analyzed by real-time PCR as in panel A. Lower panel, Xbp1 mRNA splicing forms were
analyzed by semiquantitative PCR and run on 3% agarose gel. Data are expressed as fold change over the control mice set to 1. Data are the
mean of five to six mice per group  SEM. P values are reported for comparisons between indicated groups. Ctrl, control; ns, not significant.
**, P  .01; ***, P  .001.
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demonstrated by the loss of Id1
mRNA up-regulation in Smad1/5
Cre mice (Figure 5C) and lack of
phospho-Smad1/5 complex induc-
tion (Figure 5D). Activin B mRNA
was increased in both Smad1/5 Cre
and Smad1/5 Cre mice after Tm
treatment (Figure 5E). Knockout of
Smad1 and Smad5 was confirmed by
qRT-PCR (Supplemental Figure 4, A
and B), whereas, in agreement with
the in vitro data, Tm stimulated
Smad1 and Smad5 mRNA expres-
sion in the Smad1/5 Cre mice (Sup-
plemental Figure 4, A and B, gray
bars). Proper activation of ER stress
was proved by Bip mRNA induction
and Xbp1 splicing appearance (Sup-
plemental Figure 4C). As expected,
upon Tm treatment and after hepci-
din down-regulation, serum iron and
transferrin saturation were signifi-
cantly suppressed in Smad1/5 Cre
control mice; however, this was not
the case in Smad1/5 Cre mice after
Tm treatment (Figure 5, F and G).
Altogether these data confirm the re-
quirement for the SMAD1/5/8 path-
way and the involvement of specific
SMADs in hepcidin activation dur-
ing ER stress.
We then investigated the role of
the BMP-SMAD pathway in the con-
text of genetic loss of CREBH be-
cause we had previously shown that
the CREBH transcription factor is
involved in hepcidin response to
ER stress (27). In 8-week-old male
and female Creb3l3 knockout mice
treated with Tm for 5 hours, Hamp
expression was still induced as com-
pared with control but to a signifi-
cantly lesser extent than in wild-type
mice (Figure 6A). Activation of
the SMAD1/5/8 pathway was con-
firmed by the Id1 mRNA up-regula-
tion (Figure 6B) that occurred in
both wild-type and, to a lesser ex-
tent, in Creb3l3 knockout mice. In-
terestingly, the phospho-Smad1/5
induction was not prevented in the





Figure 5. The SMAD1/5 complex is essential for Hamp induction by ER stress in vivo. A, Hamp
mRNA expression was analyzed by real-time PCR and normalized to Rpl19 housekeeping mRNA
expression using total cDNA from liver of Smad1/5 Cre (control) or Smad1/5 Cre (double
knockout) male mice treated with vehicle or Tm for 5 hours. B, Hepcidin protein expression was
analyzed using total liver extracts obtained from mice treated as in panel A. Densitometric
analysis of hepcidin signal normalized to -actin expression is shown in the lower panel. A
representative immunoblot is shown. C, Id1 mRNA expression was analyzed as in panel A. D,
Phosphorylation of SMAD1/5 complex was analyzed in total liver extracts obtained from Smad1/5
Cre (control) or Smad1/5 Cre (double knockout) male mice treated with Tm for 5 hours.
Densitometric analysis of specific phospho-SMAD1/5 complex signal normalized to -actin
expression is shown in the lower panel. E, ActB mRNA expression was analyzed as in panel A.
F, Change in serum iron ( serum iron) relative to vehicle-treated mice is reported as the mean 
SEM of measured serum iron  mean serum iron of the vehicle-treated mice for each genotype.
G, Change in transferrin saturation ( Tf sat) was analyzed as in panel F. Specific mRNA
expression of vehicle-treated mice was set to 1. Data are expressed as mean  SEM of seven to
eight mice per group. P values are reported for comparisons between control and Tm-treated
mice, within each genotype. ns not significant. *, P  .05; **, P  .01; ***, P  .001.
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indicating that even in the absence of CREBH, ER stress
still activates the SMAD1/5/8 pathway.
Single Smad1 and Smad5 mRNAs were similarly ex-
pressed in both WT and knockout mice (Supplemental
Figure 5, A and B). Knockout of the Creb3l3 gene was
confirmed in the knockout mice by qRT-PCR (Supple-
mental Figure 5C).
Discussion
ER stress is associated with disruption of ER homeostasis
and accumulation of unfolded or misfolded proteins in the
ER (40). Homeostasis in the ER is tightly monitored
through a series of adaptive programs, called the unfolded
protein response (UPR). The UPR not only regulates ER
capacity and the secretory pathway but also modulates
fundamental physiological processes, such as differentia-
tion of specialized cell types or cell metabolism (41). As
such, ER stress has been involved in a number of patho-
physiological states, including inflammatory response,
nutrient disorders, and viral infection. Recently we re-
ported that the CREB3L3 (also known as CREBH), an ER
stress-associated liver-specific transcription factor that ac-
tivates the transcription of acute-phase response genes in
the liver (42), stably occupies hepcidin promoter and up-
regulates hepcidin transcription during ER stress, leading
A B
C
Figure 6. CREBH contributes to Hamp induction by ER stress in vivo. A, Hamp mRNA expression was analyzed by real time PCR and normalized in
respect to Rpl19 housekeeping mRNA expression using total cDNA from liver of Creb3l3 wild-type (WT) or Creb3l3/ (KO) mice treated with Tm
for 5 hours. B, Id1 mRNA expression was analyzed as in panel A. C, Phosphorylation of SMAD1/5 complex was analyzed using total liver extracts
from Creb3l3 WT or Creb3l3 / (KO) mice treated with Tm for 5 hours. Densitometric analysis of specific phospho-SMAD1/5 complex signal
normalized on -actin expression is shown in the lower graph. Specific mRNA expression of vehicle-treated mice was set to 1. Data are expressed
as mean  SEM of 8–10 mice per group. P values are reported for comparisons between indicated groups. ns, not significant. *, P  .05;
**, P  .01; ***, P  .001.
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to iron retention in vivo (27). Interestingly, CREBH also
controls the expression of genes involved in hepatic lipo-
genesis, fatty acid oxidation and lipolysis (30), and key
gluconeogenic genes (43), emerging as a key metabolic
regulator in the liver.
Recent studies have shown the complexity of the reg-
ulation of hepcidin transcription, indicating that, whereas
specific mediators/signals are involved in discrete regula-
tory pathways (eg, BMP-SMAD in the iron signaling path-
way and STAT3 in the IL-6/inflammatory signaling path-
way), an interplay among distinct regulatory pathways
may also contribute to the regulation of hepcidin in vivo.
In fact, in vitro studies using Hamp promoter constructs
have indicated that the proximal BMP-RE is required for a
maximal hepcidin response to IL-6 (24). Activin B, which is
up-regulated by inflammation in vivo, may contribute to the
SMAD1/5/8 pathway activation in this setting (21, 22).
In the present study, we show that hepcidin induction
by different ER stressors require an intact SMAD1/5/8
pathway and hepcidin promoter BMP-RE element for op-
timal response in vitro. This induction is likely due to a
direct effect of ER stress on the postreceptor signaling
pathway because antibodies against BMP receptor li-
gands, including activin B, which is stimulated by ER
stress (this paper) and could engage the BMP receptor
complex in a paracrine fashion and enhance SMAD phos-
phorylation, were unable to prevent hepcidin up-regula-
tion by ER stress. In fact, using a cell-permeable inhibitor
of BMP receptor activity, LDN-193189, hepcidin re-
sponse was blunted. In vivo, we confirm that the stimu-
latory effect by ER stressors activates the SMAD1/5/8 sig-
naling cascade. A key role is likely played by SMAD5,
which appears to be required in vitro for constitutive hep-
cidin expressionandwhose transcription isdistinctly stim-
ulated by ER stress. These results are corroborated by in
vivo studies showing that ER stress stimulate SMAD1/5
expression and phosphorylation, whereas this effect was
blunted in hepatocyte-specific Smad1/5 double knockout
mice. Interestingly, in the latter model, the SMAD1/5/8
pathway was not induced by ER stress, as shown by the
lack of Id1 mRNA up-regulation (Figure 5C).
CREBH is required for correct hepcidin activation fol-
lowing ER stress (27). Here we show that the genetic loss
of CREBH impairs to some extent HAMP expression, as
expected, but does not prevent induction of the SMAD1/
5/8 pathway that still sustains residual hepcidin expres-
sion in vivo. In the same mouse model, we consistently
found a reduced activation Id1 mRNA in Creb3l3 knock-
out mice (Figure 6B), a known target of the SMAD1/5/8
pathway. We speculate this might be due to a role of
CREBH in regulating Id1 promoter activity, as suggested
by previous studies (44, 45).
In conclusion, our study indicates that hepcidin induc-
tion by ER stress involves the central SMAD1/5/8 path-
way. This also implies a possible cooperation between the
CREBH and the SMAD1/5/8 pathway. Both seem to be
required for full response of hepcidin to ER stressors in
vivo. Most likely, an induction of SMADs early in the
pathway is critical, and a late cooperation of CREBH on
hepcidin promoter is important to elicit a full response of
the hepcidin gene to ER stress. The UPR is characterized
by the activation of three distinct signal transduction path-
ways mediated by inositol-requiring protein 1, protein
kinase RNA-like ER kinase, and activating transcription
factor 6, which are variably and often collectively induced
(40, 41). Future studies may address whether these
pathways individually or cooperatively trigger SMAD/
CREBH-driven hepcidin induction during ER stress.
Acknowledgments
Address all correspondence and requests for reprints to:
Antonello Pietrangelo, MD, PhD, Division of Internal Medicine
2 and Center for Hemochromatosis, Department of Medical and
Surgical Science for Children and Adults, University Hospital of
Modena, Via del Pozzo 71, 41100 Modena, Italy. E-mail:
antonello.pietrangelo@unimore.it.
This work was supported by the Telethon Grant GGP14285
(to A.P.) and by National Institutes of Health Grant R01-
DK087727 (to J.L.B.).
Disclosure Summary: J.L.B. has ownership interest in Ferru-
max Pharmaceuticals, which has licensed technology from the
Massachusetts General Hospital based on the work cited here
and in prior publications. The other authors have nothing to
disclose.
References
1. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-
bonded human peptide, exhibits antimicrobial activity. FEBS Lett.
2000;480(2–3):147–150.
2. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary an-
timicrobial peptide synthesized in the liver. J Biol Chem. 2001;
276(11):7806–7810.
3. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific
gene, encoding a protein homologous to human antimicrobial pep-
tide hepcidin, is overexpressed during iron overload. J Biol Chem.
2001;276(11):7811–7819.
4. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol. 2004;
11(4):251–254.
5. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular
iron efflux by binding to ferroportin and inducing its internalization.
Science. 2004;306(5704):2090–2093.
6. Abboud S, Haile DJ. A novel mammalian iron-regulated protein
involved in intracellular iron metabolism. J Biol Chem. 2000;
275(26):19906–19912.
7. Donovan A, Brownlie A, Zhou Y, et al. Positional cloning of ze-






/endo/article/157/10/3935/2758371 by guest on 19 February 2021
brafish ferroportin1 identifies a conserved vertebrate iron exporter.
Nature. 2000;403(6771):776–781.
8. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-reg-
ulated transporter, IREG1, implicated in the basolateral transfer of
iron to the circulation. Mol Cell. 2000;5(2):299–309.
9. Qiao B, Sugianto P, Fung E, et al. Hepcidin-induced endocytosis of
ferroportin is dependent on ferroportin ubiquitination. Cell Metab.
2012;15(6):918–924.
10. Ross SL, Tran L, Winters A, et al. Molecular mechanism of hepcidin-
mediated ferroportin internalization requires ferroportin lysines,
not tyrosines or JAK-STAT. Cell Metab. 2012;15(6):905–917.
11. Corradini E, Meynard D, Wu Q, et al. Serum and liver iron differ-
ently regulate the bone morphogenetic protein 6 (BMP6)-SMAD
signaling pathway in mice. Hepatology. 2011;54(1):273–284.
12. Ramos E, Kautz L, Rodriguez R, et al. Evidence for distinct path-
ways of hepcidin regulation by acute and chronic iron loading in
mice. Hepatology. 2011;53(4):1333–1341.
13. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia
of inflammation by inducing the synthesis of the iron regulatory
hormone hepcidin. J Clin Invest. 2004;113(9):1271–1276.
14. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin ex-
pression through STAT3. Blood. 2006;108(9):3204–3209.
15. Pietrangelo A, Dierssen U, Valli L, et al. STAT3 is required for
IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenter-
ology. 2007;132(1):294–300.
16. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze
MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expres-
sion and its inflammatory stimulation. Blood. 2007;109(1):353–
358.
17. Verga Falzacappa MV, Casanovas G, Hentze MW, Muckenthaler
MU. A bone morphogenetic protein (BMP)-responsive element in
the hepcidin promoter controls HFE2-mediated hepatic hepcidin
expression and its response to IL-6 in cultured cells. J Mol Med.
2008;86(5):531–540.
18. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin
transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci
USA. 2005;102(6):1906–1910.
19. Armitage AE, Eddowes LA, Gileadi U, et al. Hepcidin regulation by
innate immune and infectious stimuli. Blood. 2011;118(15):4129–
4139.
20. Smith CL, Arvedson TL, Cooke KS, et al. IL-22 regulates iron avail-
ability in vivo through the induction of hepcidin. J Immunol. 2013;
191(4):1845–1855.
21. Besson-Fournier C, Latour C, Kautz L, et al. Induction of activin B
by inflammatory stimuli up-regulates expression of the iron-regu-
latory peptide hepcidin through Smad1/5/8 signaling. Blood. 2012;
120(2):431–439.
22. Canali S, Core AB, Zumbrennen-Bullough KB, et al. Activin B in-
duces noncanonical SMAD1/5/8 signaling via BMP type I receptors
in hepatocytes: evidence for a role in hepcidin induction by inflam-
mation in male mice. Endocrinology. 2016;157(3):1146–1162.
23. Corradini E, Babitt JL, Lin HY. The RGM/DRAGON family of
BMP co-receptors. Cytokine Growth Factor Rev. 2009;20(5–6):
389–398.
24. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muck-
enthaler MU. Bone morphogenetic protein (BMP)-responsive ele-
ments located in the proximal and distal hepcidin promoter are
critical for its response to HJV/BMP/SMAD. J Mol Med. 2009;
87(5):471–480.
25. Truksa J, Lee P, Peng H, Flanagan J, Beutler E. The distal location
of the iron responsive region of the hepcidin promoter. Blood. 2007;
110(9):3436–3437.
26. Core AB, Canali S, Babitt JL. Hemojuvelin and bone morphogenetic
protein (BMP) signaling in iron homeostasis. Front Pharmacol.
2014;5:104.
27. Vecchi C, Montosi G, Zhang K, et al. ER stress controls iron me-
tabolism through induction of hepcidin. Science. 2009;325(5942):
877–880.
28. Misra J, Chanda D, Kim DK, et al. Curcumin differentially regulates
endoplasmic reticulum stress through transcriptional corepressor
SMILE (small heterodimer partner-interacting leucine zipper pro-
tein)-mediated inhibition of CREBH (cAMP responsive element-
binding protein H). J Biol Chem. 2011;286(49):41972–41984.
29. Shin DY, Chung J, Joe Y, et al. Pretreatment with CO-releasing
molecules suppresses hepcidin expression during inflammation and
endoplasmic reticulum stress through inhibition of the STAT3 and
CREBH pathways. Blood. 2012;119(11):2523–2532.
30. Zhang C, Wang G, Zheng Z, et al. Endoplasmic reticulum-tethered
transcription factor cAMP responsive element-binding protein, he-
patocyte specific, regulates hepatic lipogenesis, fatty acid oxidation,
and lipolysis upon metabolic stress in mice. Hepatology. 2012;
55(4):1070–1082.
31. Vecchi C, Montosi G, Garuti C, et al. Gluconeogenic signals regulate
iron homeostasis via hepcidin in mice. Gastroenterology. 2014;
146(4):1060–1069.
32. Sonnweber T, Nachbaur D, Schroll A, et al. Hypoxia induced down-
regulation of hepcidin is mediated by platelet derived growth factor
BB. Gut. 2014;63(12):1951–1959.
33. Umans L, Vermeire L, Francis A, Chang H, Huylebroeck D, Zwijsen
A. Generation of a floxed allele of Smad5 for cre-mediated condi-
tional knockout in the mouse. Genesis. 2003;37(1):5–11.
34. Tremblay KD, Dunn NR, Robertson EJ. Mouse embryos lacking
Smad1 signals display defects in extra-embryonic tissues and germ
cell formation. Development. 2001;128(18):3609–3621.
35. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of
hepcidin expression reverses anemia of chronic inflammation in
rats. Blood. 2011;118(18):4977–4984.
36. Steinbicker AU, Sachidanandan C, Vonner AJ, et al. Inhibition of
bone morphogenetic protein signaling attenuates anemia associated
with inflammation. Blood. 2011;117(18):4915–4923.
37. Mayeur C, Kolodziej SA, Wang A, et al. Oral administration of a
bone morphogenetic protein type I receptor inhibitor prevents the
development of anemia of inflammation. Haematologica. 2015;
100(2):e68–e71.
38. Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition
reduces heterotopic [corrected] ossification. Nat Med. 2008;14(12):
1363–1369.
39. Kolb PS, Ayaub EA, Zhou W, Yum V, Dickhout JG, Ask K. The
therapeutic effects of 4-phenylbutyric acid in maintaining proteos-
tasis. Int J Biochem Cell Biol. 2015;61:45–52.
40. Schroder M, Kaufman RJ. The mammalian unfolded protein re-
sponse. Annu Rev Biochem. 2005;74:739–789.
41. Wu J, Kaufman RJ. From acute ER stress to physiological roles of the
Unfolded Protein Response. Cell Death Differ. 2006;13(3):374–
384.
42. Zhang K, Shen X, Wu J, et al. Endoplasmic reticulum stress activates
cleavage of CREBH to induce a systemic inflammatory response.
Cell. 2006;124(3):587–599.
43. Lee MW, Chanda D, Yang J, et al. Regulation of hepatic gluconeo-
genesis by an ER-bound transcription factor, CREBH. Cell Metab.
2010;11(4):331–339.
44. Zhang N, Subbaramaiah K, Yantiss RK, et al. Id1 expression in
endothelial cells of the colon is required for normal response to
injury. Am J Pathol. 2015;185(11):2983–2993.
45. Ohta Y, Nakagawa K, Imai Y, Katagiri T, Koike T, Takaoka K.
Cyclic AMP enhances Smad-mediated BMP signaling through PKA-
CREB pathway. J Bone Miner Metab. 2008;26(5):478–484.






/endo/article/157/10/3935/2758371 by guest on 19 February 2021
